ICU Medical Inc
Research ICU Medical Inc (ICUI) on Bullrun: valuation model: 63.7% overvalued, market cap USD 3.70B, P/E 79.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerICUI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal63.7% overvalued
- Market capUSD 3.70B
- P/E79.9
- Financial periodFY2025
- RevenueUSD 2.23B
- Revenue growth-6.3%
- Net incomeUSD 732.00K
- Free cash flowUSD 91.80M
- Gross margin36.8%
Valuation Snapshot
Bullrun's latest valuation model marks ICU Medical Inc as 63.7% overvalued; latest market cap is USD 3.70B; P/E is 79.9.
About ICU Medical Inc
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access;
Frequently asked questions
Is ICU Medical Inc overvalued or undervalued?
Bullrun's valuation model currently marks ICU Medical Inc as 63.7% overvalued.
What is ICU Medical Inc's market cap?
ICU Medical Inc's market capitalization is USD 3.70B.
What is ICU Medical Inc's P/E ratio?
ICU Medical Inc's price-to-earnings (P/E) ratio is 79.9.
What does ICU Medical Inc do?
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands;